NASDAQ: CTORCitius Oncology Inc Stock Ownership - Who owns Citius Oncology?
Insider buying vs selling
Have Citius Oncology Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when CTOR insiders and whales buy or sell their stock.
CTOR Shareholders
What type of owners hold Citius Oncology Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Citius Pharmaceuticals Inc | 70.58% | 65,627,262 | $56.18M | Insider |
| Xiaofeng Yuan | 1.86% | 1,725,000 | $1.48M | Insider |
| Dahe Zhang | 1.86% | 1,725,000 | $1.48M | Insider |
| Leonard L. Mazur | 1.83% | 1,700,000 | $1.46M | Insider |
| Myron Z. Holubiak | 1.02% | 950,000 | $813.20k | Insider |
| Jaime Bartushak | 0.89% | 825,000 | $706.20k | Insider |
| Myron Czuczman | 0.89% | 825,000 | $706.20k | Insider |
| Joel David Mayersohn | 0.35% | 321,228 | $274.97k | Insider |
| Robert Joseph Smith | 0.32% | 300,000 | $256.80k | Insider |
| Suren G. Dutia | 0.32% | 300,000 | $256.80k | Insider |
CTOR vs Pharmaceutical Stocks
Citius Oncology Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.